Sort by

Send to

Choose Destination

Links from PubMed

Items: 6


Cancer regression in patients after transfer of genetically engineered lymphocytes.

Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA.

Science. 2006 Oct 6;314(5796):126-9. Epub 2006 Aug 31.


Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Clay TM, Custer MC, Spiess PJ, Nishimura MI.

Pathol Oncol Res. 1999;5(1):3-15. Review.


Adoptive cell transfer therapy.

Dudley ME, Rosenberg SA.

Semin Oncol. 2007 Dec;34(6):524-31. Review.


Immunotherapy for metastatic solid cancers.

Turcotte S, Rosenberg SA.

Adv Surg. 2011;45:341-60. Review.


Adoptive cell transfer as personalized immunotherapy for human cancer.

Rosenberg SA, Restifo NP.

Science. 2015 Apr 3;348(6230):62-8. doi: 10.1126/science.aaa4967. Review.


Adoptive cell transfer: a clinical path to effective cancer immunotherapy.

Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME.

Nat Rev Cancer. 2008 Apr;8(4):299-308. doi: 10.1038/nrc2355. Review.

Items per page

Supplemental Content

Write to the Help Desk